Stock Comparison

FATE ALNY
Add up to 8 stocks to compare side by side
Metric FATE
Fate Therapeutics Inc
ALNY
Alnylam Pharmaceuticals Inc
Price $1.14 $328.16
Change % +8.57% -0.93%
Market Cap 131.50M 43.35B
P/E Ratio 20.2 995.2
EPS $0.23 $0.23
52W High $6.09 $495.55
52W Low $2.58 $205.87
Volume 1.48M
Avg Volume 670.6K 1.63M
Open $1.06 $331.61
Prev Close $1.05 $331.24
Div Yield
Annual Dividend
Payout Ratio
Analyst Rating Buy Strong buy
Price Target $5.75 $102.31
Total Analysts 18 36